Explore Starodub latest updates

EU eCTD Update – Implementation of Module 1 v3.1.1 & Validation Criteria v8.2

EU-Japan Biotech Mission & BioJapan 2025

Selection of non-clinical models for ATMP development

BioEurope Vienna 3 – 5 November 2025

Have you explored our white paper on the nIVD MA ToC yet?

Understanding new post-market surveillance requirements for medical devices

Palleos and Starodub Announce Strategic Partnership to Streamline Regulatory Pathways for Clinical Trials

Starodub B.V. is heading to China!

Festival of Biologics 30 September – 2 October 2025, Basel

Beyond Pride Month: Building Inclusion Every Day

GMP Guidelines: Rapid advancement of digital technologies and the implementation of AI

First Joint Clinical Assessments (JCAs) begin under EU HTA Regulation

Unified Quality Management Systems

Major Changes Ahead for CTD Modules 2 & 3: ICH Releases Draft M4Q(R2) for Public Consultation

Nonclinical safety assessment with New Approach Methodologies (NAMs): partner with us for regulatory success! 

Our 2025 company outing was unforgettable

MEB Planning Tool Mandatory from 1 July 2025

ICH Q1A Guideline – Stability Testing of Drug Substances and Products – open for consultation

Kim Bruggink
Senior RA Consultant
Kim Bruggink

Let's Connect

Talk to an expert